# Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immune-checkpoint-therapy-for-solid-tumours-clinical-dilemmas-and-future-trends/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qian Sun,Zhenya Hong,Cong Zhang,Liangliang Wang,Zhiqiang Han,Ding Ma |
| Citations | 574 |
| DOI | 10.1038/s41392-023-01522-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41392-023-01522-4.pdf |
| OpenAlex ID | https://openalex.org/W4386200638 |
| PMID | 37635168 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Ding Ma](https://scholariq.org/researchers/ding-ma/)

## Paper journal

- [Signal Transduction and Targeted Therapy](https://scholariq.org/journals/signal-transduction-and-targeted-therapy/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.